Update Reimbursement Scheme Cresemba®
The health insurer does not fully reimburse Cresemba® 40 mg and 100 mg. The producer of this medicine has therefore asked TBR...
Update Reimbursement Scheme Metoject®
From January 1, 2025 the use of Metoject Pen® 7.5mg will be fully reimbursed by the Health Insurer. For this reason the...
Reimbursement Scheme Mounjaro KwikPen® for the indication Diabetes Mellitus type 2
The health insurer does not fully reimburse Mounjaro KwikPen for the indication Diabetes Mellitus type 2. The producer of this...
Reimbursement Scheme Veoza®
Reimbursement Scheme for VEOZA® (fezolinetant) 45 mg for the treatment of moderate to severe vasomotor symptoms (VMS) associated...
Update Reimbursement Scheme Elvanse®
TBR Nederland hereby informs you that from now on the conditions regarding the Reimbursement Scheme Elvanse® 20 mg, 30 mg, 40 mg,...
Select your medicine
Check your medicine expenses
Quickly check the maximum contribution you have to pay for your medicine